{"name":"Arsanis","permalink":"arsanis","crunchbase_url":"http://www.crunchbase.com/company/arsanis","homepage_url":"http://www.arsanis.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"office@arsanis.com","phone_number":"","description":"","created_at":"Wed Feb 09 03:32:34 UTC 2011","updated_at":"Tue Mar 01 04:21:37 UTC 2011","overview":"<p>Arsanis, Inc. was incorporated in 2010 and is based in Lebanon, New Hampshire. Arsanis also operates as Arsanis Biosciences in Vienna, Austria, and according to a job posting, the company is focused on developing infectious disease treatments based on similar â€œbacterial protein and carbohydrate antigensâ€ as GlycoFi. </p>","image":{"available_sizes":[[[150,49],"assets/images/resized/0012/4388/124388v1-max-150x150.png"],[[248,82],"assets/images/resized/0012/4388/124388v1-max-250x250.png"],[[248,82],"assets/images/resized/0012/4388/124388v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Executive Director ","person":{"first_name":"Errik","last_name":"B. Anderson","permalink":"errik-b-anderson","image":null}}],"competitions":[],"providerships":[],"total_money_raised":"$10M","funding_rounds":[{"round_code":"a","source_url":"http://www.news-medical.net/news/20110228/Arsanis-closes-Series-A-financing-for-2410-million.aspx","source_description":"Arsanis closes Series A financing for $10 million","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":28,"investments":[{"company":null,"financial_org":{"name":"OrbiMed Advisors","permalink":"orbimed-advisors","image":{"available_sizes":[[[150,42],"assets/images/resized/0005/0248/50248v1-max-150x150.png"],[[203,58],"assets/images/resized/0005/0248/50248v1-max-250x250.png"],[[203,58],"assets/images/resized/0005/0248/50248v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Polaris Venture Partners","permalink":"polaris-venture-partners","image":{"available_sizes":[[[150,36],"assets/images/resized/0001/1153/11153v1-max-150x150.png"],[[163,40],"assets/images/resized/0001/1153/11153v1-max-250x250.png"],[[163,40],"assets/images/resized/0001/1153/11153v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"SV Life Sciences","permalink":"sv-life-sciences","image":{"available_sizes":[[[150,70],"assets/images/resized/0004/5361/45361v1-max-150x150.jpg"],[[250,117],"assets/images/resized/0004/5361/45361v1-max-250x250.jpg"],[[267,125],"assets/images/resized/0004/5361/45361v1-max-450x450.jpg"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"Campus Vienna Biocenter 4","address2":"Dr. Bohr-Gasse 3","zip_code":"A-1030","city":"Vienna","state_code":null,"country_code":"AUT","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[],"external_links":[]}